Akzo Nobel Management

Management criteria checks 2/4

Akzo Nobel's CEO is Greg Poux-Guillaume, appointed in Nov 2022, has a tenure of 1.5 years. total yearly compensation is €4.93M, comprised of 24.8% salary and 75.2% bonuses, including company stock and options. directly owns 0.004% of the company’s shares, worth €448.69K. The average tenure of the management team and the board of directors is 5.6 years and 4.3 years respectively.

Key information

Greg Poux-Guillaume

Chief executive officer

€4.9m

Total compensation

CEO salary percentage24.8%
CEO tenure1.5yrs
CEO ownership0.004%
Management average tenure5.6yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Should You Investigate Akzo Nobel N.V. (AMS:AKZA) At €66.58?

Mar 25
Should You Investigate Akzo Nobel N.V. (AMS:AKZA) At €66.58?

We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Mar 10
We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Feb 23
Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 44% Undervaluation?

Jan 24
Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 44% Undervaluation?

When Should You Buy Akzo Nobel N.V. (AMS:AKZA)?

Dec 13
When Should You Buy Akzo Nobel N.V. (AMS:AKZA)?

These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Reasonably Well

Nov 02
These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Reasonably Well

Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 94% Above Its Share Price

Oct 04
Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 94% Above Its Share Price

Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching

Sep 04
Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching

Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher

Aug 07
Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher

Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Jul 24
Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 36% Below Their Intrinsic Value Estimate

Jun 28
Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 36% Below Their Intrinsic Value Estimate

Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?

May 31
Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?

Returns On Capital At Akzo Nobel (AMS:AKZA) Have Hit The Brakes

Apr 28
Returns On Capital At Akzo Nobel (AMS:AKZA) Have Hit The Brakes

We Think Akzo Nobel (AMS:AKZA) Is Taking Some Risk With Its Debt

Feb 26
We Think Akzo Nobel (AMS:AKZA) Is Taking Some Risk With Its Debt

At €68.92, Is It Time To Put Akzo Nobel N.V. (AMS:AKZA) On Your Watch List?

Feb 12
At €68.92, Is It Time To Put Akzo Nobel N.V. (AMS:AKZA) On Your Watch List?

Is Akzo Nobel N.V. (AMS:AKZA) Trading At A 26% Discount?

Jan 16
Is Akzo Nobel N.V. (AMS:AKZA) Trading At A 26% Discount?

These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively

Is It Time To Consider Buying Akzo Nobel N.V. (AMS:AKZA)?

Nov 06
Is It Time To Consider Buying Akzo Nobel N.V. (AMS:AKZA)?

Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 91% Above Its Share Price

Oct 12
Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 91% Above Its Share Price

Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?

Aug 12
Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?

Why Akzo Nobel's (AMS:AKZA) Shaky Earnings Are Just The Beginning Of Its Problems

Jul 28
Why Akzo Nobel's (AMS:AKZA) Shaky Earnings Are Just The Beginning Of Its Problems

Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?

Jul 10
Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?

Akzo Nobel (AMS:AKZA) Has A Pretty Healthy Balance Sheet

May 11
Akzo Nobel (AMS:AKZA) Has A Pretty Healthy Balance Sheet

Akzo Nobel (AMS:AKZA) Will Pay A Larger Dividend Than Last Year At €1.54

Apr 15
Akzo Nobel (AMS:AKZA) Will Pay A Larger Dividend Than Last Year At €1.54

At €78.10, Is Akzo Nobel N.V. (AMS:AKZA) Worth Looking At Closely?

Apr 10
At €78.10, Is Akzo Nobel N.V. (AMS:AKZA) Worth Looking At Closely?

Akzo Nobel (AMS:AKZA) Is Increasing Its Dividend To €1.54

Mar 27
Akzo Nobel (AMS:AKZA) Is Increasing Its Dividend To €1.54

Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 47% Undervaluation?

Mar 22
Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 47% Undervaluation?

Akzo Nobel's (AMS:AKZA) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 06
Akzo Nobel's (AMS:AKZA) Shareholders Will Receive A Bigger Dividend Than Last Year

Akzo Nobel (AMS:AKZA) Is Paying Out A Larger Dividend Than Last Year

Feb 20
Akzo Nobel (AMS:AKZA) Is Paying Out A Larger Dividend Than Last Year

Here's Why We Think Akzo Nobel (AMS:AKZA) Is Well Worth Watching

Jan 13
Here's Why We Think Akzo Nobel (AMS:AKZA) Is Well Worth Watching

Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Jan 02
Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 38%?

Dec 20
Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 38%?

Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?

Dec 08
Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?

Here's Why We Think Akzo Nobel (AMS:AKZA) Is Well Worth Watching

Oct 10
Here's Why We Think Akzo Nobel (AMS:AKZA) Is Well Worth Watching

Does Akzo Nobel (AMS:AKZA) Have A Healthy Balance Sheet?

Sep 27
Does Akzo Nobel (AMS:AKZA) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Akzo Nobel N.V. (AMS:AKZA) Suggests It's 31% Undervalued

Sep 15
An Intrinsic Calculation For Akzo Nobel N.V. (AMS:AKZA) Suggests It's 31% Undervalued

Is It Time To Consider Buying Akzo Nobel N.V. (AMS:AKZA)?

Sep 04
Is It Time To Consider Buying Akzo Nobel N.V. (AMS:AKZA)?

Does Akzo Nobel (AMS:AKZA) Deserve A Spot On Your Watchlist?

Jul 05
Does Akzo Nobel (AMS:AKZA) Deserve A Spot On Your Watchlist?

These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Reasonably Well

Jun 24
These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Reasonably Well

Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 26% Below Their Intrinsic Value Estimate

Jun 12
Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 26% Below Their Intrinsic Value Estimate

Is Now The Time To Look At Buying Akzo Nobel N.V. (AMS:AKZA)?

May 30
Is Now The Time To Look At Buying Akzo Nobel N.V. (AMS:AKZA)?

CEO Compensation Analysis

How has Greg Poux-Guillaume's remuneration changed compared to Akzo Nobel's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

€534m

Dec 31 2023€5m€1m

€447m

Sep 30 2023n/an/a

€411m

Jun 30 2023n/an/a

€309m

Mar 31 2023n/an/a

€303m

Dec 31 2022€2m€204k

€362m

Compensation vs Market: Greg's total compensation ($USD5.31M) is above average for companies of similar size in the Dutch market ($USD3.90M).

Compensation vs Earnings: Greg's compensation has increased by more than 20% in the past year.


CEO

Greg Poux-Guillaume (53 yo)

1.5yrs

Tenure

€4,934,990

Compensation

Mr. Grégoire Poux-Guillaume, also known as Greg, was Chairman of the Board at medmix AG since September 20, 2021 and continues to serve as Director. He had been the Chief Executive Officer at Sulzer, Ltd.,...


Leadership Team

NamePositionTenureCompensationOwnership
Grégoire Poux-Guillaume
CEO & Chairman of the Management Board1.5yrs€4.93m0.0042%
€ 448.7k
Maarten de Vries
CFO & Member of Management Board6.3yrs€2.77m0.014%
€ 1.5m
Roger Jakeman
Chief Technology Officerno datano datano data
Kyung Chae
Head Of Investor Relationsno datano datano data
Charlotte Meer
General Counselless than a yearno datano data
Leslie McGibbon
Global Head of Communications & Public Affairs and Corporate Director8.9yrsno datano data
Armand Sohet
Chief Human Resources Officerless than a yearno datano data
Renier Vree
Chief Financial Officer of Specialty Chemicals Business6.2yrsno datano data
Charles Shaver
CEO of Specialty Chemicals5.6yrsno datano data
Karen-Marie Katholm
Chief Integrated Supply Chain Officer2.7yrsno datano data
G. Gramser
Group Treasurer8.3yrsno datano data
Myrthe Bijleveld - de Kooning
Corporate Secretaryno datano datano data

5.6yrs

Average Tenure

57yo

Average Age

Experienced Management: AKZA's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ben Noteboom
Independent Supervisory Board Chairman1.1yrs€109.29kno data
Byron Grote
Independent Deputy Chairman of the Supervisory Board10.1yrs€133.00k0.0058%
€ 622.6k
Patrick Thomas
Independent Member of the Supervisory Board6.5yrs€112.50kno data
Hans Van Bylen
Independent Member of Supervisory Board2.1yrs€107.50kno data
Dick Sluimers
Independent Member of the Supervisory Board9.3yrs€100.00kno data
Ester Baiget
Independent Member of Supervisory Board2.1yrs€110.00kno data

4.3yrs

Average Tenure

65.5yo

Average Age

Experienced Board: AKZA's board of directors are considered experienced (4.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.